Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies

J Natl Cancer Inst. 2012 Jul 18;104(14):NP. doi: 10.1093/jnci/djs278.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Colony-Stimulating Factors / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Disseminated Intravascular Coagulation / therapy
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Evidence-Based Medicine
  • Graft vs Host Disease / prevention & control*
  • Hematologic Neoplasms / drug therapy*
  • Hematologic Neoplasms / surgery*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hodgkin Disease / drug therapy
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / surgery
  • Leukemia, Myeloid, Acute / surgery
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy
  • Randomized Controlled Trials as Topic
  • Receptors, Thrombopoietin / agonists
  • Remission Induction
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Vinblastine / administration & dosage
  • Vincristine / administration & dosage
  • Viral Vaccines / administration & dosage

Substances

  • Colony-Stimulating Factors
  • Receptors, Thrombopoietin
  • Viral Vaccines
  • Bleomycin
  • MPL protein, human
  • Procarbazine
  • Vincristine
  • Vinblastine
  • Etoposide
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • BEACOPP protocol